AM3, A NEW ORAL ROUTE BIOLOGICAL MODIFIER - PHARMACOLOGICAL AND CLINICAL ASPECTS

被引：0
|
作者：
TUDURI, P
VELASCO, R
MARTINEZ, A
GUERRERO, A
PIVEL, JP
VILLARRUBIA, VG
SADA, G
机构：
[1] ANDROMACO LABS,DEPT RES,MADRID,SPAIN
[2] ANDROMACO LABS,DEPT MED,MADRID,SPAIN
来源：
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1985年 / 7卷 / 03期
关键词：
D O I：
10.1016/0192-0561(85)90190-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [31] CLINICAL ASPECTS OF A NEW LOW-DOSED COMBINED ORAL-CONTRACEPTIVE
    MLADENOVIC, D
    GRCIC, R
    PESTELEK, B
    KAPOR, M
    FORTSCHRITTE DER MEDIZIN, 1978, 96 (13) : 723 - 726
  • [32] CLINICAL ASPECTS OF 3 NEW PROGESTOGENS - DESOGESTREL, GESTODENE, AND NORGESTIMATE
    CHEZ, RA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1989, 160 (05) : 1296 - 1300
  • [33] NEW CLINICAL ASPECTS OF PEARSONS SYNDROME - REPORT OF 3 CASES
    FAVARETO, F
    CAPRINO, D
    MICALIZZI, C
    ROSANDA, C
    BOERI, E
    MORI, PG
    HAEMATOLOGICA, 1989, 74 (06) : 591 - 594
  • [34] New Insights Into Oral Squamous Cell Carcinoma: From Clinical Aspects to Molecular Tumorigenesis
    Chen, Shang-Hung
    Hsiao, Sheng-Yen
    Chang, Kwang-Yu
    Chang, Jang-Yang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 21
  • [35] Enhancing effects of new biological response modifier β-1,3 glucan sulfate PS3 on immune reactions
    Vetvicka, Vaclav
    Vetvickova, Jana
    Frank, Jamois
    Yvin, Jean-Claude
    BIOMEDICINE & PHARMACOTHERAPY, 2008, 62 (05) : 283 - 288
  • [36] Biological aspects of new organotin(IV) compounds of 3-maleimidopropionic acid
    Khan, MI
    Baloch, MK
    Ashfaq, M
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2004, 689 (21) : 3370 - 3378
  • [37] Biological aspects of 3D conformal radiotherapy: Prostate cancer as a clinical example
    Bentzen, SM
    RADIATION RESEARCH, VOL 2, CONGRESS PROCEEDINGS, 2000, : 648 - 652
  • [38] A new manganese-based oral contrast agent (CMC-001) for liver MRI: pharmacological and pharmaceutical aspects
    Jorgensen, Jan Trost
    Rief, Matthias
    Brismar, Torkel B.
    Wagner, Moritz
    Albiin, Nils
    ACTA RADIOLOGICA, 2012, 53 (07) : 707 - 713
  • [39] PHARMACOLOGICAL AND CLINICAL EVALUATION OF ACTIVITY AND TOLERANCE OF A NEW ORAL ANTIDIABETIC COMPOUND GLYDIAZINAMIDE OR K-4024
    PARODI, FA
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1972, 8 (06): : 888 - &
  • [40] Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects
    Bronte, Giuseppe
    Rolfo, Christian
    Giovannetti, Elisa
    Cicero, Giuseppe
    Pauwels, Patrick
    Passiglia, Francesco
    Castiglia, Marta
    Rizzo, Sergio
    Lo Vullo, Francesca
    Fiorentino, Eugenio
    Van Meerbeeck, Jan
    Russo, Antonio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2014, 89 (02) : 300 - 313
12345